![Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML]()
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AMLBultitude, Will P.; Schellekens, Jennifer; Szydlo, Richard M.; Anthias, Chloe; Cooley, Sarah A.; Miller, Jeffrey S.; Weisdorf, Daniel J.; Shaw, Bronwen E.; Roberts, Chrissy h.; Garcia-Sepulveda, Christian A.; Lee, Julia; Pearce, Rachel M.; Wilson, Marie C.; Potter, Michael N.; Byrne, Jenny L.; Russell, Nigel H.; MacKinnon, Stephen; Bloor, Adrian J.; Patel, Amit; McQuaker, I. Grant; Malladi, Ram; Tholouli, Eleni; Orchard, Kim; Potter, Victoria T.; Madrigal, J. Alejandro; Mayor, Neema P.; Marsh, Steven G. E. · Bone Marrow Transplantation · 2020